Oral semaglutide: the innovation in type 2 diabetes management

por M. V. Shestakova, M. Sh. Shamkhalova, G. R. Galstyan, L. A. Ruyatkina, L. A. Suplotova
Publicado 2021

Endocrinology research centre statement about COVID-19 vaccination of diabetes mellitus patients

por I. I. Dedov, M. V. Shestakova, A. Yu. Mayorov, T. V. Nikonova, G. R. Galstyan, M. Sh. Shamkhalova, O. K. Vikulova, V. Yu. Kalashnikov, N. G. Mokrysheva
Publicado 2021